to page content
to site navigation
Mr. Martin joined Pacific Biosciences in 2004 as a seasoned executive with a 25-year track record managing leading edge technologies, new ventures, and high growth businesses. Previously, Mr. Martin was Chairman,
President and CEO of ONI Systems?a high-speed optical telecommunications company he founded in 1998 and took public in 2000. Named the Fastest Growing Company in Silicon Valley in 2001, ONI was sold to Ciena in 2002. After its sale, Mr.
Martin served as a consultant to Ciena, a CEO in residence at the venture capital firm of Kleiner Perkins Caufield and Byers, and was a Director at Cloudshield Technologies. Prior to ONI, Mr. Martin was President and Director of 3DO?an
interactive gaming company. His earlier experience includes running desktop engineering for Apple Computer and founding Ridge Computers?designer of the world's first commercial reduced instruction set computing (RISC) minicomputer. Mr.
Martin received a BS in Electrical Engineering at Rutgers University, New Brunswick, New Jersey. Mr. Martin currently serves on the Board of Directors of Pacific Biosciences and Infinera.
Hugh Martin, Chairman and CEO of Pacific Biosciences, looks back on the evolution of his career - from building computers to creating the future of medicine. Martin charts the lessons he learned working for large technology firms, as a leader in several successful start-ups, and while being courted by the VC community to launch a new wave in bioscience.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.